Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Therapeutics and Clinical Risk Management ◽

10.2147/tcrm.s148840 ◽

2018 ◽

Vol Volume 14 ◽

pp. 833-847 ◽

Author(s):

Sooyoung Shin ◽

Yoojin Noh

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Adverse Drug Events ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Randomized Controlled ◽

Bevacizumab Treatment ◽

Download Full-text

Increased risk of cardiac conduction abnormalities with ribociclib in patients with metastatic breast cancer: A combined analysis of phase III randomized controlled trials

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2020.03.001 ◽

2020 ◽

Author(s):

Somedeb Ball ◽

Sriman Swarup ◽

Anita Sultan ◽

Kyaw Zin Thein

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Metastatic Breast ◽

Phase Iii ◽

Cardiac Conduction ◽

Controlled Trials ◽

Combined Analysis ◽

Randomized Controlled ◽

Download Full-text

Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Breast Cancer ◽

10.1007/s12282-020-01052-9 ◽

2020 ◽

Vol 27 (3) ◽

pp. 347-354 ◽

Author(s):

Minoru Miyashita ◽

Masaya Hattori ◽

Toshimi Takano ◽

Tatsuya Toyama ◽

Hiroji Iwata

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Randomized Controlled ◽

Risks And Benefits

Download Full-text

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

Current Medical Research and Opinion ◽

10.1185/03007995.2012.756393 ◽

2012 ◽

Vol 29 (2) ◽

pp. 117-125 ◽

Author(s):

Wei-Xiang Qi ◽

Zan Shen ◽

Feng Lin ◽

Yuan-jue Sun ◽

Da-liu Min ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Efficacy of gemcitabine-based chemotherapy in metastatic breast cancer: a meta-analysis of randomized controlled trials

Current Medical Research and Opinion ◽

10.1185/03007995.2013.832185 ◽

2013 ◽

Vol 29 (11) ◽

pp. 1443-1452 ◽

Author(s):

Weibing Li ◽

Hongbiao Wang ◽

Xuyuan Li

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials

Tumor Biology ◽

10.1007/s13277-014-1635-4 ◽

2014 ◽

Vol 35 (5) ◽

pp. 4841-4848 ◽

Author(s):

Xuan Wang ◽

Chun Huang ◽

Man Li ◽

Yanjun Gu ◽

Yanfen Cui ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Paclitaxel-Based Versus Docetaxel-Based Regimens in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Annals of Oncology ◽

10.1016/s0923-7534(20)32975-6 ◽

2012 ◽

Vol 23 ◽

pp. ix119

Author(s):

W. Qi ◽

Y. Yao ◽

Z. Shen ◽

F. Lin ◽

Y. Sun ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

Scientific Reports ◽

10.1038/srep15746 ◽

2015 ◽

Vol 5 (1) ◽

Author(s):

Qin Li ◽

Han Yan ◽

Pengfei Zhao ◽

Yifan Yang ◽

Bangwei Cao

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Efficacy and Safety of Eribulin Compared with Control Therapy in Patients with Locally Advanced or Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

Value in Health ◽

10.1016/j.jval.2018.07.070 ◽

2018 ◽

Vol 21 ◽

pp. S10

Author(s):

A Pagada ◽

RK Mishra ◽

P Bolshete ◽

MK Rai

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Locally Advanced ◽

Metastatic Breast ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Control Therapy

Download Full-text

Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trials

Investigational New Drugs ◽

10.1007/s10637-009-9310-0 ◽

2009 ◽

Vol 29 (1) ◽

pp. 182-188 ◽

Author(s):

Jae-Bok Lee ◽

Ok Hee Woo ◽

Kyong Hwa Park ◽

Sang Uk Woo ◽

Dae Sik Yang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Salvage Treatment ◽

Systemic Review ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

HER2-targeted regimens after prior trastuzumab for patients with HER2-positive unresectable, locally advanced or metastatic breast cancer: a network meta-analysis of randomized controlled trials

Annals of Translational Medicine ◽

10.21037/atm-20-5149 ◽

2020 ◽

Vol 8 (24) ◽

pp. 1634-1634

Author(s):

Xinghui Li ◽

Songwen Wu ◽

Lijie Zhang ◽

Ji Zhu ◽

Binghe Xu

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Locally Advanced ◽

Metastatic Breast ◽

Controlled Trials ◽

Her2 Positive ◽

Randomized Controlled

Download Full-text